About Dipeptidyl peptidase 1
Dipeptidyl peptidase 1 (CTSC) is a protein
from Homo sapiens identified by UniProt accession
P53634, 463 residues long.
MolForge cross-references it against 0 known binders and
260 disease associations.
Target properties
| Protein name | Dipeptidyl peptidase 1 |
| UniProt accession | P53634 |
| Gene | CTSC |
| Organism | Homo sapiens |
| Length | 463 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (2)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (260)
Diseases linked to this target (Open Targets).
- Papillon-Lefèvre syndrome · score 0.83
- Haim-Munk syndrome · score 0.80
- aggressive periodontitis · score 0.78
- Papillon-Lefevre disease · score 0.77
- periodontitis · score 0.73
- chronic periodontitis · score 0.73
- blood protein measurement · score 0.49
- monocyte count · score 0.47
- Palmoplantar keratoderma · score 0.46
- CTSC-related disorder · score 0.40
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P53634-F1 | alphafold | PREDICTED | 90.13 | — |
Amino-acid sequence (463 residues)
MGAGPSLLLA ALLLLLSGDG AVRCDTPANC TYLDLLGTWV FQVGSSGSQR DVNCSVMGPQ EKKVVVYLQK LDTAYDDLGN SGHFTIIYNQ GFEIVLNDYK WFAFFKYKEE GSKVTTYCNE TMTGWVHDVL GRNWACFTGK KVGTASENVY VNIAHLKNSQ EKYSNRLYKY DHNFVKAINA IQKSWTATTY MEYETLTLGD MIRRSGGHSR KIPRPKPAPL TAEIQQKILH LPTSWDWRNV HGINFVSPVR NQASCGSCYS FASMGMLEAR IRILTNNSQT PILSPQEVVS CSQYAQGCEG GFPYLIAGKY AQDFGLVEEA CFPYTGTDSP CKMKEDCFRY YSSEYHYVGG FYGGCNEALM KLELVHHGPM AVAFEVYDDF LHYKKGIYHH TGLRDPFNPF ELTNHAVLLV GYGTDSASGM DYWIVKNSWG TGWGENGYFR IRRGTDECAI ESIAVAATPI PKL
Explore Dipeptidyl peptidase 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets